These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26191606)

  • 1. Bile Acid Conjugated DNA Chimera that Conditionally Inhibits Carbonic Anhydrase-II in the Presence of MicroRNA-21.
    Chu X; Battle CH; Zhang N; Aryal GH; Mottamal M; Jayawickramarajah J
    Bioconjug Chem; 2015 Aug; 26(8):1606-12. PubMed ID: 26191606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as potent carbonic anhydrase inhibitors: synthesis, biological evaluation, and enzyme--ligand X-ray studies.
    Gitto R; Agnello S; Ferro S; De Luca L; Vullo D; Brynda J; Mader P; Supuran CT; Chimirri A
    J Med Chem; 2010 Mar; 53(6):2401-8. PubMed ID: 20170095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
    Żołnowska B; Sławiński J; Pogorzelska A; Chojnacki J; Vullo D; Supuran CT
    Eur J Med Chem; 2014 Jan; 71():135-47. PubMed ID: 24291567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring new Probenecid-based carbonic anhydrase inhibitors: Synthesis, biological evaluation and docking studies.
    Mollica A; Costante R; Akdemir A; Carradori S; Stefanucci A; Macedonio G; Ceruso M; Supuran CT
    Bioorg Med Chem; 2015 Sep; 23(17):5311-8. PubMed ID: 26264840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel 2-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)-1-(1,3,5-triazin-2-ylamino)guanidine derivatives: Inhibition of human carbonic anhydrase cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, anticancer activity, and molecular modeling studies.
    Żołnowska B; Sławiński J; Szafrański K; Angeli A; Supuran CT; Kawiak A; Wieczór M; Zielińska J; Bączek T; Bartoszewska S
    Eur J Med Chem; 2018 Jan; 143():1931-1941. PubMed ID: 29146134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dopaminergic compounds on carbonic anhydrase isozymes I, II, and VI.
    Sentürk M; Ekinci D; Göksu S; Supuran CT
    J Enzyme Inhib Med Chem; 2012 Jun; 27(3):365-9. PubMed ID: 21699374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of piperazines as human carbonic anhydrase I, II, IV and VII activators.
    Angeli A; Chiaramonte N; Manetti D; Romanelli MN; Supuran CT
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):303-308. PubMed ID: 29280407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human carbonic anhydrase isozymes I, II and VI with a series of bisphenol, methoxy and bromophenol compounds.
    Balaydin HT; Durdaği S; Ekinci D; Sentürk M; Göksu S; Menzek A
    J Enzyme Inhib Med Chem; 2012 Aug; 27(4):467-75. PubMed ID: 21815772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with N-hydroxysulfamides--a new zinc-binding function in the design of inhibitors.
    Winum JY; Innocenti A; Nasr J; Montero JL; Scozzafava A; Vullo D; Supuran CT
    Bioorg Med Chem Lett; 2005 May; 15(9):2353-8. PubMed ID: 15837324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facile synthesis and characterization of novel pyrazole-sulfonamides and their inhibition effects on human carbonic anhydrase isoenzymes.
    Balseven H; Mustafa İşgör M; Mert S; Alım Z; Beydemir S; Ok S; Kasımoğulları R
    Bioorg Med Chem; 2013 Jan; 21(1):21-7. PubMed ID: 23218470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of novel N,N'-diaryl cyanoguanidines acting as potent and selective carbonic anhydrase II inhibitors.
    Akocak S; Lolak N; Bua S; Turel I; Supuran CT
    Bioorg Chem; 2018 Apr; 77():245-251. PubMed ID: 29421699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX.
    Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3102-8. PubMed ID: 15905091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbonic anhydrase inhibitors: Inhibition of human erythrocyte isozymes I and II with a series of phenolic acids.
    Sarikaya SB; Gülçin I; Supuran CT
    Chem Biol Drug Des; 2010 May; 75(5):515-20. PubMed ID: 20486938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorinated pyrrolidines and piperidines incorporating tertiary benzenesulfonamide moieties are selective carbonic anhydrase II inhibitors.
    Le Darz A; Mingot A; Bouazza F; Castelli U; Karam O; Tanc M; Supuran CT; Thibaudeau S
    J Enzyme Inhib Med Chem; 2015; 30(5):737-45. PubMed ID: 25431145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbonic anhydrase II-induced selection of inhibitors from a dynamic combinatorial library of Schiff's bases.
    Nasr G; Petit E; Supuran CT; Winum JY; Barboiu M
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6014-7. PubMed ID: 19796939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human carbonic anhydrase isoenzymes I and II (hCA I and II) inhibition effects of trimethoxyindane derivatives.
    Taslimi P; Gulcin I; Ozgeris B; Goksu S; Tumer F; Alwasel SH; Supuran CT
    J Enzyme Inhib Med Chem; 2016; 31(1):152-7. PubMed ID: 25697270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors.
    Ramya PVS; Angapelly S; Angeli A; Digwal CS; Arifuddin M; Babu BN; Supuran CT; Kamal A
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1274-1281. PubMed ID: 28965419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isoforms I and II and transmembrane, tumor-associated isoforms IX and XII with boronic acids.
    Winum JY; Innocenti A; Scozzafava A; Montero JL; Supuran CT
    Bioorg Med Chem; 2009 May; 17(10):3649-52. PubMed ID: 19375921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The synthesis of novel sulfamides derived from β-benzylphenethylamines as acetylcholinesterase, butyrylcholinesterase and carbonic anhydrase enzymes inhibitors.
    Akıncıoğlu A; Kocaman E; Akıncıoğlu H; Salmas RE; Durdagi S; Gülçin İ; Supuran CT; Göksu S
    Bioorg Chem; 2017 Oct; 74():238-250. PubMed ID: 28866249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbonic anhydrase inhibitors. X-ray crystal studies of the carbonic anhydrase II-trithiocarbonate adduct--an inhibitor mimicking the sulfonamide and urea binding to the enzyme.
    Temperini C; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2010 Jan; 20(2):474-8. PubMed ID: 20005709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.